Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $65.8 million.

  • SOPHiA GENETICS's Total Non-Current Liabilities rose 9808.07% to $65.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.8 million, marking a year-over-year increase of 9808.07%. This contributed to the annual value of $32.0 million for FY2024, which is 6768.45% up from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's Total Non-Current Liabilities is $65.8 million, which was up 9808.07% from $66.4 million recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's Total Non-Current Liabilities peaked at $66.4 million during Q2 2025, and registered a low of $8.0 million during Q2 2021.
  • For the 5-year period, SOPHiA GENETICS's Total Non-Current Liabilities averaged around $25.7 million, with its median value being $18.3 million (2022).
  • Data for SOPHiA GENETICS's Total Non-Current Liabilities shows a peak YoY increase of 12569.65% (in 2022) and a maximum YoY decrease of 465.48% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Total Non-Current Liabilities stood at $16.2 million in 2021, then rose by 4.5% to $16.9 million in 2022, then grew by 12.99% to $19.1 million in 2023, then skyrocketed by 67.68% to $32.0 million in 2024, then surged by 105.66% to $65.8 million in 2025.
  • Its last three reported values are $65.8 million in Q3 2025, $66.4 million for Q2 2025, and $32.2 million during Q1 2025.